Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ADP-ribosylation factor-like protein 5B (ARL5B) is a small GTPase of the ARF-like (ARL) family and is structurally related to the well-known ADP-ribosylation factors (ARFs), belonging to the Ras superfamily of regulatory GTPases[3][10]. It localizes primarily to the trans-Golgi network, where it binds and exchanges GTP and GDP, and is involved in regulating retrograde transport from endosomes to the trans-Golgi and the distribution of key membrane cargo proteins[1][2][4]. Studies suggest ARL5B may also play a role in cell survival and metabolic processes such as apoptosis and glycolysis in some cancer cell types[9]. However, there are currently no known drugs targeting ARL5B and its function is primarily characterized by its involvement in vesicle-mediated intracellular transport rather than as a pharmacological target[3][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ADP-ribosylation factor-like protein 5B (ARL5B).